QSP-27612-47044
3 vaccinations
1 coded response
38 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 474 / IN
- Registered
- 2021-04-28
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-28
Registered in v-safe
-
2021-04-28
Dose 1 — Pfizer-BioNTech
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-12
-
2021-05-19
Dose 2 — Pfizer-BioNTech
- 2021-05-19
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-05-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Muscle or body achesAdult check-in
- 2021-05-22
-
2021-05-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-05-24
- 2021-05-25
- 2021-05-26
-
2021-06-02
Survey response — day 14, dose 2MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Extreme headache for two days straightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-09
- 2021-06-16
- 2021-06-23
- 2021-06-30
- 2021-08-18
- 2021-11-21
-
2021-12-17
Dose 3 — Pfizer-BioNTech
- 2021-12-17
-
2021-12-18
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint painsAdult check-in
- 2021-12-20
- 2021-12-21
- 2021-12-22
- 2021-12-24
- 2021-12-31
- 2022-01-08
- 2022-01-14
- 2022-01-21
- 2022-01-28
- 2022-03-18
- 2022-06-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-28 | Pfizer-BioNTech | |
| 2 | 2021-05-19 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
Free text
Release 8 — day 14, dose 2
Symptoms: Extreme headache for two days straight
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release